ALZN
Alzamend Neuro, Inc.
NASDAQHealthcareBiotechnologyUS
USD1.15
+0.01 (+0.88%)
Rating:C-
Company Profile
CEO
Stephan Jackman
IPO Date
2021-06-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.13
Prev. Close
$1.14
Day Low
$1.11
Day High
$1.16
52W Low
$0.84
52W High
$4.00
Market Cap
$0.00B
Volume
0.03M